Mumbai based IPCA gets a shot in the arm as USFDA suspends import ban for key Covid-19 drug

IPCA has a market share of nearly 70% of these drugs, as it is one of the largest suppliers of the active pharmaceutical ingredient of these medicines to several large multinational drug companies. Since the Covid-19 outbreak the company has supplied nearly 5 lakh tablets across the world.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UuEN3t
via IFTTT